Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
GT Biopharma, Inc. (GTBP) had Return on Investments of -489.96% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-34.45M |
|
-- |
|
-- |
|
$12.42M |
|
$-12.42M |
|
$-15.93M |
|
$-28.35M |
|
$-28.35M |
|
$-28.35M |
|
$-28.35M |
|
$-28.35M |
|
$-28.35M |
|
$-12.42M |
|
$-12.42M |
|
5.51M |
|
5.51M |
|
$-6.68 |
|
$-6.68 |
|
| Balance Sheet Financials | |
$8.11M |
|
-- |
|
-- |
|
$8.11M |
|
$2.32M |
|
-- |
|
-- |
|
$2.32M |
|
$5.79M |
|
$5.79M |
|
$5.79M |
|
25.53M |
|
| Cash Flow Statement Financials | |
$-12.91M |
|
-- |
|
$15.78M |
|
$4.04M |
|
$6.91M |
|
$2.86M |
|
$0.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-490.04% |
|
-489.96% |
|
-349.79% |
|
|
Return on Investments |
-489.96% |
$0.23 |
|
$-2.34 |
|
$-2.34 |
|